If there is any real, quantifiable & repeatable evidence out there that truly offers a benefit from its tandem use, then it is important that it is explored. But the use of Dendritic cells in this adjuvant manner, is hardly exclusive to NWBO,is it ?
I just don’t believe that DCVAX-L is the ‘cure all’ it’s made out to be by proponents of this stock.?
The paid for promotions in journals is hardly conclusive proof as to its efficacy, is it ?
For it has yet to be approved by any National Regulator for Marketing.
In any event, every published puff piece is just the same old cut n paste piece.
And when there is additional commentary, it is typical a negative critique of the trial format & data.
Market Data 
Markets 
AI
